Transdermal Patch Drug Delivery System Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Transdermal Patch Drug Delivery System Market is expected to grow at a CAGR of 6% during the forecast period 2022-2028. 

Transdermal patches are a method of delivering drugs directly through the skin into the bloodstream. The patch provides a controlled, continuously administered drug that is easily consumed, has minimal side effects, and is non-invasive. Drug delivery patches mainly have a polymer matrix, a drug, a penetration enhancer and an adhesive layer. Transdermal patches have an advantage over other injectable and oral systems because they avoid first-pass metabolism and are easier to maintain drug concentrations. There are mainly three ways drug molecules can penetrate the body through the skin: the shunt pathway, the intercellular lipid domain, and the transcellular pathway. Transdermal patches allow drugs to reach their biolocation with minimal side effects. They are based on backing laminators, liners and plasticizers that ensure good adhesion and efficient drug release through the skin in the form of systemic circulation for hours or days.

Market Segments

By Type

• Shunt Way
• Intercellular Lipid Structure Pathway
• Trans-cellular Pathway

By Application

• Pain Management
• Central Nervous System
• Hormonal Application
• Cardiovascular Disease

Key Players

• Hisamitsu Pharmaceutical
• Novartis
• ProSolus
• Tapemark
• Tesa Labtec
• NITTO DENKO CORPORATION
• Noven Pharmaceuticals
• LTS Lohmann Therapie-Systeme
• Medherant

Scope of the Report

The research study analyzes the global Transdermal Patch Drug Delivery System industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Transdermal Patch Drug Delivery System Market Report

1. What was the Transdermal Patch Drug Delivery System Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Transdermal Patch Drug Delivery System Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Transdermal Patch Drug Delivery System Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.